ROCKAWAY, NJ, Sept. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that...
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Perception Neuroscience (Perception), an atai Life Sciences (atai) biopharmaceutical company...
SHANGHAI and MIAMI, Sept. 14, 2021 (GLOBE NEWSWIRE) -- LeaderMed Health Group Limited, a pharmaceutical development company with operations based...
Industry veteran strengthens Pyxis team with expertise in clinical development, medical affairs and antibody-drug conjugates (ADCs)CAMBRIDGE, Mass., Sept. 14, 2021...
Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies, which began in...
-- Trial designed to assess safety, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of MDNA11 in patients with advanced solid...
ORANGE, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, a mission-based Medicare Advantage insurance company, today announced the appointment...
PITTSBURGH, Sept. 14, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company...
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development...
SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated...
Data demonstrate superiority of HIFU versus radical prostatectomy among prostate cancer patients LYON, France, September 14, 2021 -- EDAP TMS...
BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel...
ST. LOUIS and BERN, Switzerland, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a clinical-stage biopharmaceutical company focused on the...
•NXP900 is a SRC/YES1 Kinase Inhibitor with a Novel and Differentiated Mechanism of Action.FORT LEE, NJ , Sept. 14, 2021...
MAPS to Investigate Viability of Research Pathway for MDMA-Assisted Therapy to Treat Traumatic Brain Injury Effort Positions MAPS, Sponsor of...
GMPi certification has been confirmed by INVIMA.The certification covers Phytotherapeutics manufactured with PharmaCielo´s extracts and proprietary cultivars.PharmaCielo’s Processing and Extraction Centre...
GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today...
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a...
